Association of hormonal contraception and HIV-seroprevalence in Nairobi, Kenya.
Among women attending family planning clinics in Nairobi, Kenya, the HIV-seroprevalence rates for different contraceptive methods were: depomedroxyprogesterone acetate (DMPA) 431/3279 (13.1%), combination oral contraceptive pill 114/1073 (10.6%), and progesterone-only contraceptive pill (POCP) 45/741 (6.1%). After adjusting for age, marital status, and parity, women using the POCP had a lower HIV seroprevalence (adjusted odds ratio 0.5, 95% confidence interval 0.3-0.7) than women using DMPA. This association was most pronounced among POCP users of lower parity.
Criniti
Amy
A
Department of Obstetrics and Gynecology, University of Washington, Seattle, USA.
Mwachari
Christina W
CW
Meier
Amalia S
AS
Nduba
Videlis
V
Sanguli
Lucy
L
Ngumo
James K
JK
Cohen
Craig R
CR
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D018791:CD4 Lymphocyte Count; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use*; D004198:Disease Susceptibility; D005260:Female; D006679:HIV Seropositivity / Q000453:epidemiology*; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D010298:Parity; D011374:Progesterone / Q000627:therapeutic use*; D016036:Seroepidemiologic Studies
D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D011374:Progesterone; D017258:Medroxyprogesterone Acetate